Autoimmune hepatitis: A review

Talha Malik, Shehzad Saeed

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Autoimmune Hepatitis (AIH) is a periportal hepatitis with increased immunoglobulins and auto antibodies, which primarily responds to immunosuppression. It affects women 3.6 times more commonly than men. It is postulated that an environmental agent, either a drug or a virus or another agent seems to trigger a T-cell mediated cascade directed against liver antigens in genetically predisposed individuals to cause AIH. Diagnosis requires exclusion of other causes of liver disease. The diagnostic criteria have been defined in a simplified scoring system introduced by the International Autoimmune Hepatitis Group (IAIHG) in 2008. Current treatment of AIH is based on guidelines published by the American Association for the Study of Liver Diseases (AASLD) in 2002 and comprises of corticosteroids with azathioprine. Steroids tend to carry a high complication risk profile; hence several newer immunomodulators and biologics are in different stages of trials to assess their efficacy and safety.

Original languageEnglish (US)
Pages (from-to)381-387
Number of pages7
JournalJournal of the Pakistan Medical Association
Volume60
Issue number5
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Autoimmune Hepatitis
Azathioprine
Immunologic Factors
Biological Products
Immunosuppression
Hepatitis
Immunoglobulins
Liver Diseases
Adrenal Cortex Hormones
Steroids
Guidelines
Viruses
T-Lymphocytes
Safety
Antigens
Antibodies
Liver
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Autoimmune hepatitis : A review. / Malik, Talha; Saeed, Shehzad.

In: Journal of the Pakistan Medical Association, Vol. 60, No. 5, 01.01.2010, p. 381-387.

Research output: Contribution to journalReview article

Malik, Talha ; Saeed, Shehzad. / Autoimmune hepatitis : A review. In: Journal of the Pakistan Medical Association. 2010 ; Vol. 60, No. 5. pp. 381-387.
@article{94d89de2b0064be384e9b6b4f92a1663,
title = "Autoimmune hepatitis: A review",
abstract = "Autoimmune Hepatitis (AIH) is a periportal hepatitis with increased immunoglobulins and auto antibodies, which primarily responds to immunosuppression. It affects women 3.6 times more commonly than men. It is postulated that an environmental agent, either a drug or a virus or another agent seems to trigger a T-cell mediated cascade directed against liver antigens in genetically predisposed individuals to cause AIH. Diagnosis requires exclusion of other causes of liver disease. The diagnostic criteria have been defined in a simplified scoring system introduced by the International Autoimmune Hepatitis Group (IAIHG) in 2008. Current treatment of AIH is based on guidelines published by the American Association for the Study of Liver Diseases (AASLD) in 2002 and comprises of corticosteroids with azathioprine. Steroids tend to carry a high complication risk profile; hence several newer immunomodulators and biologics are in different stages of trials to assess their efficacy and safety.",
author = "Talha Malik and Shehzad Saeed",
year = "2010",
month = "1",
day = "1",
language = "English (US)",
volume = "60",
pages = "381--387",
journal = "JPMA. The Journal of the Pakistan Medical Association",
issn = "0030-9982",
publisher = "Pakistan Medical Association",
number = "5",

}

TY - JOUR

T1 - Autoimmune hepatitis

T2 - A review

AU - Malik, Talha

AU - Saeed, Shehzad

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Autoimmune Hepatitis (AIH) is a periportal hepatitis with increased immunoglobulins and auto antibodies, which primarily responds to immunosuppression. It affects women 3.6 times more commonly than men. It is postulated that an environmental agent, either a drug or a virus or another agent seems to trigger a T-cell mediated cascade directed against liver antigens in genetically predisposed individuals to cause AIH. Diagnosis requires exclusion of other causes of liver disease. The diagnostic criteria have been defined in a simplified scoring system introduced by the International Autoimmune Hepatitis Group (IAIHG) in 2008. Current treatment of AIH is based on guidelines published by the American Association for the Study of Liver Diseases (AASLD) in 2002 and comprises of corticosteroids with azathioprine. Steroids tend to carry a high complication risk profile; hence several newer immunomodulators and biologics are in different stages of trials to assess their efficacy and safety.

AB - Autoimmune Hepatitis (AIH) is a periportal hepatitis with increased immunoglobulins and auto antibodies, which primarily responds to immunosuppression. It affects women 3.6 times more commonly than men. It is postulated that an environmental agent, either a drug or a virus or another agent seems to trigger a T-cell mediated cascade directed against liver antigens in genetically predisposed individuals to cause AIH. Diagnosis requires exclusion of other causes of liver disease. The diagnostic criteria have been defined in a simplified scoring system introduced by the International Autoimmune Hepatitis Group (IAIHG) in 2008. Current treatment of AIH is based on guidelines published by the American Association for the Study of Liver Diseases (AASLD) in 2002 and comprises of corticosteroids with azathioprine. Steroids tend to carry a high complication risk profile; hence several newer immunomodulators and biologics are in different stages of trials to assess their efficacy and safety.

UR - http://www.scopus.com/inward/record.url?scp=77951233189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951233189&partnerID=8YFLogxK

M3 - Review article

C2 - 20527613

AN - SCOPUS:77951233189

VL - 60

SP - 381

EP - 387

JO - JPMA. The Journal of the Pakistan Medical Association

JF - JPMA. The Journal of the Pakistan Medical Association

SN - 0030-9982

IS - 5

ER -